Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Advertising
Top Story
Chlamydia
U.K. funds development of rapid point-of-care test for gonorrhea, chlamydia
University of Birmingham spinout Linear Diagnostics is developing a point-of-care test designed to show if a person is infected with chlamydia or gonorrhea in 20 minutes.
Featured
Regulatory Approval
Cue Health granted first traditional FDA authorization for at-home test to detect respiratory illness
Molecular Diagnostics
Low rates of genetic testing ‘a missed opportunity’ to reduce cancer burden
Latest News
PreCheck Health Services launches NGS cancer panel
June 9, 2023
Sponsored
Visit our Molecular Diagnostics Community
June 7, 2023
Quantification of long COVID fatigue shows impact is worse than some cancers
June 8, 2023
Taking metformin during SARS-CoV-2 infection cuts risk of long COVID in clinical trial
June 9, 2023
Stay in the Know
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Sign Up
Business Insights
Stock
Precipio prices $2M stock offering and concurrent private placement
Collaboration
GrapheneDx, General Graphene, Sapphiros partner to develop graphene IVD biosensors
Skin Cancer
FDA clears DeepX Diagnostics digital dermatoscope to screen for suspected skin cancer lesions
Regulatory Approval
Seegene obtains IVDR certification for 30 diagnostic assays
Diagnostic Technologies
COVID-19
Quantification of long COVID fatigue shows impact is worse than some cancers
Sequencing
Burning Rock Biotech highlights breast cancer study using its genomic profiling test
Collaboration
Thermo Fisher Scientific, Seer expand collaboration to broaden access to mass-spec proteomics
Collaboration
GrapheneDx, General Graphene, Sapphiros partner to develop graphene IVD biosensors
Diseases
Guideline
CAP, ASCO reduce confusion by reaffirming HER2 testing guidelines
Sepsis
Prenosis nabs $749K federal contract to study clinical utility of AI-based diagnostic tool for sepsis
Antibiotic Resistance
Metagenomics study finds antibiotic resistance genes are widespread among bacteria
Skin Cancer
FDA clears DeepX Diagnostics digital dermatoscope to screen for suspected skin cancer lesions
More from LabPulse.com
Blood sugar maintenance mechanism revealed in DNA study
DNA study reveals how healthy blood sugar levels are maintained after eating — and how that process may go wrong in type 2 diabetes.
June 9, 2023
CAP, ASCO reduce confusion by reaffirming HER2 testing guidelines
The organizations reaffirmed the Human Epidermal Growth Factor Receptor 2 (HER2) Breast Cancer Testing Guidelines, reducing confusion over terminology for reporting HER2 results.
June 8, 2023
Burning Rock Biotech highlights breast cancer study using its genomic profiling test
In the study, OncoScreen Plus was used to determine activating mutations in PIK3CA and AKT1 and inactivating alterations in PTEN genes for patients in the trial who were enrolled in China.
June 8, 2023
Precipio prices $2M stock offering and concurrent private placement
The specialty cancer diagnostics company intends to use the net proceeds for working capital and general corporate purposes.
June 8, 2023
FDA updates recommendations to modernize design, conduct of clinical trials
The objective is to make clinical trials more agile without compromising data integrity or protection for study participants, the agency said.
June 7, 2023
Thermo Fisher Scientific, Seer expand collaboration to broaden access to mass-spec proteomics
Seer will establish the Seer Technology Access Center to showcase its latest product, the Proteograph XT Assay Kit, in combination with the Thermo Scientific Orbitrap Astral mass spectrometer.
June 7, 2023
GrapheneDx, General Graphene, Sapphiros partner to develop graphene IVD biosensors
GrapheneDx's first tests to be released under the collaboration will be for the diagnosis of sexually transmitted infections, including chlamydia and gonorrhea, using a urine sample.
June 7, 2023
Prenosis nabs $749K federal contract to study clinical utility of AI-based diagnostic tool for sepsis
The firm’s Sepsis ImmunoScore is a pathogen-agnostic, host-based digital diagnostic tool that uses artificial intelligence/machine learning to predict sepsis using clinical parameters and protein biomarkers.
June 7, 2023
Metagenomics study finds antibiotic resistance genes are widespread among bacteria
Bacteria everywhere carry previously unknown genes that make them resistant to antibiotics, potentially aggravating the problem of untreatable bacterial infections.
June 6, 2023
FDA clears DeepX Diagnostics digital dermatoscope to screen for suspected skin cancer lesions
The device has conducted more than 180 thousand assessments in pharmacies and primary care clinics in Europe; DeepX is poised to enter the U.S. market.
June 6, 2023
Dante Genomics introduces rare disease health package that leverages telemedicine, sequencing
The package includes telemedicine consultations with specialists who may not be available where a patient is located.
June 6, 2023
'AI doctor' predicts hospital readmission, health outcomes
New AI program reads doctors' notes to predict health outcomes, including patients' risk of death, hospital stay length, and likelihood of readmission.
June 7, 2023
